Peginterferon alfa-2b as monotherapy or in combination with lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomised study. [electronic resource]
Producer: 20090402Description: CR56-61 p. digitalISSN:- 1643-3750
- Alanine Transaminase -- metabolism
- Antiviral Agents -- pharmacology
- DNA, Viral -- analysis
- Drug Therapy, Combination
- Female
- Hepatitis B e Antigens -- immunology
- Hepatitis B virus -- drug effects
- Hepatitis B, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- pharmacology
- Lamivudine -- pharmacology
- Male
- Middle Aged
- Polyethylene Glycols
- Recombinant Proteins
- Regression Analysis
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.